• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在貌似健康的人群中,血浆二肽基肽酶 IV 活性与身体成分测量。

Plasma dipeptidyl peptidase IV activity and measures of body composition in apparently healthy people.

机构信息

The School of Kinesiology, Auburn University, Auburn, Alabama, USA.

The Department of Nutrition, Dietetics and Hospitality Management, Auburn University, Auburn, Alabama, USA.

出版信息

Heliyon. 2016 Apr 18;2(4):e00097. doi: 10.1016/j.heliyon.2016.e00097. eCollection 2016 Apr.

DOI:10.1016/j.heliyon.2016.e00097
PMID:27441271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4946079/
Abstract

AIM

Based on its regulatory action on glucagon-like peptide 1, dipeptidyl peptidase IV (DPP-IV) has increasingly been linked to Type 2 diabetes. However, there is no evidence as to how this normal modulatory enzyme leads to pathology. It is thought that DPP-IV is affected by the development of obesity, which is a common precursor to Type 2 diabetes. Little is known about the relationship between DPP-IV activity in plasma and specific body composition measures.

MAIN METHODS

In the current study, plasma DPP-IV activity and body composition measures were collected from 111 healthy subjects between the ages of 19 and 70 years old for analysis.

KEY FINDINGS

The mean plasma DPP-IV activity was 35.9U/L ± 12.3, falling within normal reference value range presented by Durinx et al. DPP-IV activity was negatively correlated with absolute body fat mass, but absolute lean mass was positively correlated. Consistent with the findings, DPP-IV activity was also negatively correlated with absolute gynoid fat (p = 0.0047). DPP-IV activity did not have a significant correlation with absolute android fat mass, visceral adipose tissue, BMI, and age.

SIGNIFICANCE

From these results, it can be concluded that high activity of DPP-IV is not indicative of pathology, and specific body composition components may influence soluble DPP-IV activity in the blood.

摘要

目的

基于对胰高血糖素样肽 1 的调节作用,二肽基肽酶 4(DPP-IV)与 2 型糖尿病的关系日益密切。然而,目前尚不清楚这种正常的调节酶如何导致病理学。人们认为 DPP-IV 受肥胖的影响,肥胖是 2 型糖尿病的常见前兆。关于血浆 DPP-IV 活性与特定身体成分测量之间的关系知之甚少。

主要方法

在目前的研究中,从 111 名年龄在 19 至 70 岁的健康受试者中收集血浆 DPP-IV 活性和身体成分测量值进行分析。

主要发现

平均血浆 DPP-IV 活性为 35.9U/L ± 12.3,处于 Durinx 等人提出的正常参考值范围内。DPP-IV 活性与绝对体脂肪量呈负相关,而与绝对瘦体重呈正相关。与研究结果一致,DPP-IV 活性也与绝对女性型脂肪(p=0.0047)呈负相关。DPP-IV 活性与绝对男性型脂肪量、内脏脂肪组织、BMI 和年龄无显著相关性。

意义

从这些结果可以得出结论,DPP-IV 活性高并不表明存在病理学,特定的身体成分可能会影响血液中可溶性 DPP-IV 活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/4a2f45ff5ff6/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/8fc32b550d9e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/51ca43f46876/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/b9a078e76131/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/e86e508e4101/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/c29f003a0924/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/4a2f45ff5ff6/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/8fc32b550d9e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/51ca43f46876/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/b9a078e76131/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/e86e508e4101/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/c29f003a0924/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7821/4946079/4a2f45ff5ff6/gr6.jpg

相似文献

1
Plasma dipeptidyl peptidase IV activity and measures of body composition in apparently healthy people.在貌似健康的人群中,血浆二肽基肽酶 IV 活性与身体成分测量。
Heliyon. 2016 Apr 18;2(4):e00097. doi: 10.1016/j.heliyon.2016.e00097. eCollection 2016 Apr.
2
Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.长期抑制二肽基肽酶-IV对高脂饮食喂养小鼠身体组成和葡萄糖耐量的影响。
Life Sci. 2009 Jun 19;84(25-26):876-81. doi: 10.1016/j.lfs.2009.03.022. Epub 2009 Apr 7.
3
Increased plasma dipeptidyl peptidase IV (DPP IV) activity and decreased DPP IV activity of visceral but not subcutaneous adipose tissue in impaired glucose tolerance rats induced by high-fat or high-sucrose diet.在高脂或高糖饮食诱导的糖耐量受损大鼠中,血浆二肽基肽酶IV(DPP IV)活性升高,内脏脂肪组织而非皮下脂肪组织的DPP IV活性降低。
Biol Pharm Bull. 2009 Mar;32(3):463-7. doi: 10.1248/bpb.32.463.
4
Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.接受胆胰分流术的病态肥胖患者的胰高血糖素样肽1(GLP-1)分泌及血浆二肽基肽酶IV(DPP-IV)活性
Horm Metab Res. 2004 Feb;36(2):111-5. doi: 10.1055/s-2004-814222.
5
Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus.高血糖会增加糖尿病患者体内二肽基肽酶IV的活性。
Diabetologia. 2005 Jun;48(6):1168-72. doi: 10.1007/s00125-005-1749-8. Epub 2005 Apr 29.
6
Tissue expression of DPP-IV in obesity-diabetes and modulatory effects on peptide regulation of insulin secretion.肥胖-糖尿病中 DPP-IV 的组织表达及其对胰岛素分泌肽调节的调节作用。
Peptides. 2018 Feb;100:165-172. doi: 10.1016/j.peptides.2017.12.020.
7
High DPP-4 Concentrations in Adolescents Are Associated With Low Intact GLP-1.青少年中高浓度的 DPP-4 与低完整 GLP-1 有关。
J Clin Endocrinol Metab. 2018 Aug 1;103(8):2958-2966. doi: 10.1210/jc.2018-00194.
8
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.二肽基肽酶-IV抑制剂西他列汀多次口服给药的药代动力学和药效学特性:一项在健康男性志愿者中进行的双盲、随机、安慰剂对照研究
Clin Ther. 2006 Jan;28(1):55-72. doi: 10.1016/j.clinthera.2006.01.015.
9
DPP-IV inhibition enhances the antilipolytic action of NPY in human adipose tissue.DPP-IV 抑制增强了 NPY 在人体脂肪组织中的抗脂肪分解作用。
Diabetes Obes Metab. 2009 Apr;11(4):285-92. doi: 10.1111/j.1463-1326.2008.00909.x. Epub 2009 Jan 19.
10
(2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.(2S,4S)-4-氟-1-[[(2-羟基-1,1-二甲基乙基)氨基]乙酰基]-2-吡咯烷甲腈单苯磺酸盐(TS-021)是一种选择性和可逆的二肽基肽酶 IV 抑制剂。
Eur J Pharmacol. 2011 Mar 25;655(1-3):99-107. doi: 10.1016/j.ejphar.2011.01.010. Epub 2011 Jan 22.

引用本文的文献

1
Profiling of proteases involved in SARS-CoV-2 pathogenesis in human saliva: Influence of age and gender.新冠病毒致病过程中人类唾液中蛋白酶的分析:年龄和性别的影响
J Genet Eng Biotechnol. 2025 Sep;23(3):100509. doi: 10.1016/j.jgeb.2025.100509. Epub 2025 Jun 17.
2
Comparison of DPPIV Levels in Serum and Tumour of OSCC Patients and Its Correlation with Active Matrix Metalloproteinases 2 and 9.口腔鳞状细胞癌患者血清和肿瘤中 DPPIV 水平的比较及其与活性基质金属蛋白酶 2 和 9 的相关性。
Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1343-1349. doi: 10.31557/APJCP.2023.24.4.1343.
3
Dipeptidyl Peptidase IV as a Muscle Myokine.

本文引用的文献

1
Adiponectin, chemerin, cytokines, and dipeptidyl peptidase 4 are released from human adipose tissue in a depot-dependent manner: an in vitro system including human serum albumin.脂联素、趋化素、细胞因子和二肽基肽酶 4 以依赖脂肪库的方式从人脂肪组织中释放:包括人血清白蛋白的体外系统。
BMC Endocr Disord. 2014 Jan 22;14:7. doi: 10.1186/1472-6823-14-7.
2
Precision of the iDXA for visceral adipose tissue measurement in severely obese patients.iDXA测量重度肥胖患者内脏脂肪组织的精度。
Med Sci Sports Exerc. 2014 Jul;46(7):1462-5. doi: 10.1249/MSS.0000000000000238.
3
Body fat distribution and insulin resistance.
二肽基肽酶IV作为一种肌肉肌动蛋白
Front Physiol. 2020 Mar 3;11:148. doi: 10.3389/fphys.2020.00148. eCollection 2020.
4
Association between Serum Dipeptidyl Peptidase-4 Concentration and Obesity-related Factors in Health Screen Examinees.健康筛查受检者血清二肽基肽酶-4浓度与肥胖相关因素之间的关联
J Obes Metab Syndr. 2017 Sep;26(3):188-196. doi: 10.7570/jomes.2017.26.3.188. Epub 2017 Sep 30.
5
Dipeptidyl Peptidase 4 Activity Is Related to Body Composition, Measures of Adiposity, and Insulin Resistance in Subjects with Excessive Adiposity and Different Degrees of Glucose Tolerance.在肥胖人群中,二肽基肽酶 4 活性与身体成分、肥胖指标和胰岛素抵抗有关,且与葡萄糖耐量的不同程度有关。
J Diabetes Res. 2019 Feb 11;2019:5238013. doi: 10.1155/2019/5238013. eCollection 2019.
6
Obesity parameters, physical activity, and physical fitness are correlated with serum dipeptidyl peptidase IV activity in a healthy population.在健康人群中,肥胖参数、身体活动及体能与血清二肽基肽酶IV活性相关。
Heliyon. 2018 May 14;4(5):e00627. doi: 10.1016/j.heliyon.2018.e00627. eCollection 2018 May.
体脂肪分布与胰岛素抵抗。
Nutrients. 2013 Jun 5;5(6):2019-27. doi: 10.3390/nu5062019.
4
Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells.鉴定和验证源自原代人骨骼肌细胞的新型收缩调节肌因子。
PLoS One. 2013 Apr 24;8(4):e62008. doi: 10.1371/journal.pone.0062008. Print 2013.
5
Pathophysiology of human visceral obesity: an update.人类内脏肥胖的病理生理学:更新。
Physiol Rev. 2013 Jan;93(1):359-404. doi: 10.1152/physrev.00033.2011.
6
Arcuate NPY neurons sense and integrate peripheral metabolic signals to control feeding.弓状核 NPY 神经元感知和整合外周代谢信号,以控制摄食。
Neuropeptides. 2012 Dec;46(6):315-9. doi: 10.1016/j.npep.2012.09.004. Epub 2012 Oct 26.
7
Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people.健康年轻人的血浆二肽基肽酶 4 活性与体重指数和血浆脂联素浓度相关。
Endocr J. 2012;59(10):949-53. doi: 10.1507/endocrj.ej12-0158. Epub 2012 Jun 23.
8
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity.肠道激素与食欲控制:以 PYY 和 GLP-1 为肥胖治疗靶点
Gut Liver. 2012 Jan;6(1):10-20. doi: 10.5009/gnl.2012.6.1.10. Epub 2012 Jan 12.
9
NPY and stress 30 years later: the peripheral view.30 年后的 NPY 与压力:外周观点。
Cell Mol Neurobiol. 2012 Jul;32(5):645-59. doi: 10.1007/s10571-011-9793-z. Epub 2012 Jan 24.
10
Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors.二肽基肽酶 IV 活性测定方法的比较及其在含有可逆抑制剂的生物样品中的应用。
Clin Chim Acta. 2012 Feb 18;413(3-4):456-62. doi: 10.1016/j.cca.2011.10.031. Epub 2011 Nov 7.